156 related articles for article (PubMed ID: 8891154)
1. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
Hunt Gerardo S; Citron DM; Claros MC; Goldstein EJ
Antimicrob Agents Chemother; 1996 Oct; 40(10):2413-5. PubMed ID: 8891154
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
3. Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Spangler SK; Lin G; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 May; 42(5):1253-5. PubMed ID: 9593160
[TBL] [Abstract][Full Text] [Related]
4. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Plouffe JF
Diagn Microbiol Infect Dis; 1996 May; 25(1):43-5. PubMed ID: 8831044
[TBL] [Abstract][Full Text] [Related]
5. Comparative in-vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections.
Casellas JM; Gilardoni M; Tome G; Goldberg M; Ivanovic S; Orduna M; Dolmann A; Ascoli M; Ariza H; Montero JM
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():37-42. PubMed ID: 10404336
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
White RL; Enzweiler KA; Friedrich LV; Wagner D; Hoban D; Bosso JA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):207-17. PubMed ID: 12106954
[TBL] [Abstract][Full Text] [Related]
7. Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.
Clark CL; Jacobs MR; Appelbaum PC
J Clin Microbiol; 1998 Dec; 36(12):3579-84. PubMed ID: 9817876
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Sun H; Chen L; Chen X; Jia X; Li N; Liu W; Tong H; Xiang R; Zhang F; Zhao H; Zhang J; Xu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Jan; 39(1):30-7. PubMed ID: 26792053
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the in-vitro activity of levofloxacin against Streptococcus pneumoniae.
Reinert RR; Lütticken R; Lemperle M; Bryskier A
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():5-8. PubMed ID: 10404330
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
[TBL] [Abstract][Full Text] [Related]
12. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
Esposito S; Noviello S; Ianniello F
Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.
Nicodemo AC; Mendes CM; Oplustil CP; Sinto S
Braz J Infect Dis; 2001 Apr; 5(2):50-2. PubMed ID: 11493408
[TBL] [Abstract][Full Text] [Related]
14. The susceptibility of Streptococcus pneumoniae to levofloxacin and other antibiotics.
Keller N; Smollen G; Davidson Y; Barzilai A; Keren G; Rubinstein E
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():1-3. PubMed ID: 10404329
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
[TBL] [Abstract][Full Text] [Related]
17. Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
Black J; Moland ES; Chartrand SA; Thomson KS
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):195-7. PubMed ID: 11337189
[TBL] [Abstract][Full Text] [Related]
18. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Sugita K; Katouno Y; Uchida H; Kobayashi Y
Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
[TBL] [Abstract][Full Text] [Related]
19. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 1996 May; 25(1):47-51. PubMed ID: 8831045
[TBL] [Abstract][Full Text] [Related]
20. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
